ANIP

Ani Pharmaceuticals
$71.46
+$0.76 (+1.07%)Sep 10, 2026
8.5GreatMoatMint rating

MoatMint rates Ani Pharmaceuticals (ANIP) 8.5 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 8.3 out of 10.

Key metrics

The numbers that frame ANIP today
Market cap
$1.64B
P/E (TTM)
15.2
EV / FCF
10.9
Gross margin
60.4%
EV / Sales
1.9
ROIC
16.8%
Div yield
0%
Debt / equity
1.0
52wk Low
$69.96
52wk High
$99.50

ANIP stock rating

How ANIP scores on quality, value, growth, momentum and financial health
8.5out of 10
Great overallHealthy business, attractive price
Quality8.3
Growth9.2
Momentum2.7
Value9.1
Financial Health8.6

Growth

Revenue and earnings trend for ANIP
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about ANIP
Is Ani Pharmaceuticals a good buy?
Yes. Ani Pharmaceuticals has excellent quality, and it outweighs the poor momentum here. Growth looks excellent, which supports the long-term business case. We think Ani Pharmaceuticals is selling at a low price.
What is the market capitalization of ANIP?
Ani Pharmaceuticals's market capitalization is $1.64B.
What is the P/E ratio for ANIP stock?
Ani Pharmaceuticals's current P/E ratio is 15.2.
What is the 52-week high for ANIP stock?
The 52-week high for Ani Pharmaceuticals is $99.50. The current close of $71.46 is 28.2% below that high.
What is the 52-week low for ANIP stock?
The 52-week low for Ani Pharmaceuticals is $69.96. The current close of $71.46 is 2.1% above that low.
Does ANIP stock pay dividends?
Ani Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ANIP?
Ani Pharmaceuticals's Debt / Equity ratio is 1.02.